Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

During the Trading Day
8.43 -0.99 / -10.51%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
8.43 0.00 / 0.00%
 
Volume: 13.5K

Today’s Trading

Previous close9.42
Today’s open9.61
Day’s range8.28 - 9.61
Volume1,798,618
Average volume (3 months)1,412,608
Market cap$656.1M
Dividend yield--
Data as of 4:00pm ET, 07/29/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-950.00%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)+464.45%
P/E ratio169.3
Price/Sales11.63
Price/Book5.25

Competitors

 Today’s
change
Today’s
% change
OTICOtonomy Inc-1.17-4.29%
PETXAratana Therapeutics...-0.40-2.18%
OMEDOncoMed Pharmaceutic...-0.38-1.80%
COCPCocrystal Pharma Inc-0.02-2.02%
Data as of 4:00pm ET, 07/29/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$44.4M
Annual profit (last year)$4.4M
Net profit margin9.94%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark Robert Baker
CFO, Treasurer, Principal Accounting Officer &
VP
Angelo William Lovallo
Corporate headquarters
Tarrytown, New York

Forecasts